James V Hennessey MD

TYROSINE KINASE INHIBITORS in MANAGEMENT of AGGRESSIVE DIFFERENTIATED THYROID CANCER James V Hennessey MD

This small book offers up to the minute information on a serious medical problem- management of differentiated thyroid cancer no longer amendable to surgery or RAI. It covers contemporary initial diagnosis and treatment, making an evidence based decision to move beyond RAI therapy, detailed and practical information on use of tyrosine kinase targeted treatment, and a look at what may come after single-agent TKIs. The authors are all steeped in management of thyroid cancer, including Furio Pacini and Leslie De Groot, Martin Schlumberger, Michael Tuttle and Monica Sabra, Joshua Klopper and Brian Haugen, James Fagin, and James Hennesey. The symposium is presented by www. Thyroidmanager.org and www. Endotext.org, in which pages it was initially published.